Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 33Recruiting 22Active not recruiting 18Terminated 9Withdrawn 2Unknown 2Not yet recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Lymphoma, Mantle-Cell 3Lymphoma, B-Cell 3Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

venetoclax 6zanubrutinib 3tafasitamab 2obinutuzumab 2acalabrutinib 2Specimen Handling 2Rituximab 2Biopsy 2resiniferatoxin 1pirtobrutinib 1fludarabine 1duvelisib 1Therapeutics 1Sirolimus 1Prednisone 1Observation 1Magnetic Resonance Spectroscopy 1Interleukin-2 1Immunoglobulins 1Exercise 1Everolimus 1Disulfides 1Cyclophosphamide 1Blood Cell Count 1Biopsy, Needle 1Bendamustine Hydrochloride 1Azacitidine 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Leukemia, Lymphocytic, Chronic, B-Cell × obinutuzumab × Clear all
NCT07520006 2026-04-13

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

Nurix Therapeutics, Inc.

Phase 1/2 Not yet recruiting
150 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07003464 2025-06-04

Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy for Chronic Lymphocytic Leukemia: A Single-Center Study

The First Hospital of Jilin University

Phase 2 Not yet recruiting
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡